Transvaginal Hysterosalpingo-Contrast Sonography (HyCoSy) Compared with Chromolaparoscopy
Article first published online: 24 MAY 2010
2000 Japan Society of Obstetrics and Gynecology
Journal of Obstetrics and Gynaecology Research
Volume 26, Issue 1, pages 71–75, February 2000
How to Cite
Tanawattanacharoen, S., Suwajanakorn, S., Uerpairojkit, B., Boonkasemsanti, W. and Virutamasen, P. (2000), Transvaginal Hysterosalpingo-Contrast Sonography (HyCoSy) Compared with Chromolaparoscopy. Journal of Obstetrics and Gynaecology Research, 26: 71–75. doi: 10.1111/j.1447-0756.2000.tb01205.x
- Issue published online: 24 MAY 2010
- Article first published online: 24 MAY 2010
- Received: Jan. 14, 1999; Accepted: Oct. 8, 1999
- transvaginal ultrasound;
Objective: To compare the efficacy and safety of HyCoSy with chromolaparoscopy for the diagnosis of tubal occlusion and uterine abnormalities.
Methods: Sixty infertile women in whom the cause of infertility was thought to be tubal occlusion or uterine abnormalities and who satisfied the inclusion and exclusion criteria as specified in the study protocol were included. HyCoSy was performed during the first half of the menstrual cycle at least 24 hours prior to chromolaparoscopy. The results from both HyCoSy and chromolaparoscopy were compared in assessing tubal occlusion and uterine pathology.
Results: For the evaluation of fallopian tubes, we found corresponding results between HyCoSy and chromolaparoscopy in 80.0%. The agreement between both procedures in assessing the uterine pathology was 80.4%. Twenty-two women experienced adverse events. The most common complaint was pelvic pain. Other events encountered were: nausea (3 women) and vaginal bleeding (2 women). All events were thought to be not related to the study drug.
Conclusion: HyCoSy showed good diagnostic performance in the evaluation of the fallopian tubes and uterus in infertile women. The adverse events reported in this study are minor and procedure-related (catheter insertion) rather than the trial substance.